Cancer statistics, 2012

@article{Siegel2012CancerS2,
  title={Cancer statistics, 2012},
  author={R. Siegel and D. Naishadham and A. Jemal},
  journal={CA: A Cancer Journal for Clinicians},
  year={2012},
  volume={62}
}
  • R. Siegel, D. Naishadham, A. Jemal
  • Published 2012
  • Medicine
  • CA: A Cancer Journal for Clinicians
    • Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. A total of 1,638,910 new cancer cases… CONTINUE READING
    View on Wiley
    onlinelibrary.wiley.com
    10,002 Citations
    Highly Influential Citations
    105
    Background Citations
    842
    Methods Citations
    15
    Results Citations
    11

    Paper Mentions

    Interventional Clinical Trial
    Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer
    To evaluate of the value of radical prostatectomy and extended pelvic lymph node dissection in locally advanced prostate cancer after neoadjuvant hormonal therapy with or without… Expand
    ConditionsChemotherapy Effect, Hormone Sensitive Prostate Cancer, Locally Advanced Prostate Carcinoma, (+1 more)
    InterventionDrug, Procedure
    RenJi Hospital
    January 2020 - December 2024
    Interventional Clinical Trial
    Trial of Carboplatin-Paclitaxel-Bevacizumab vs Carboplatin-Paclitaxel-Bevacizumab-Rucaparib vs Carboplatin-Paclitaxel-Rucaparib in Patients With Advanced (Stage III B-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer.
    This trial is a randomized, open-label Phase II multi-center study designed to evaluate the effect of first line therapy of Carboplatin-Paclitaxel-Bevacizumab (in combination and… Expand
    ConditionsAdvanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
    InterventionDrug
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
    February 2018 - March 2023
    Interventional Clinical Trial
    Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)
    Cabozantinib in patients with advanced penile squamous cell carcinoma (PSCC): an open-label, single-center, phase 2, single-arm trial (CaboPen)  
    ConditionsPenile Squamous Cell Carcinoma
    InterventionDrug
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
    June 2019 - September 2022
    Interventional Clinical Trial
    A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer
    Background: - Papillary RCC is the second most common histologic subtype of kidney cancer, accounting for approximately 10-15% of cases - Type 1 papillary RCC… Expand
    ConditionsKidney Cancer
    InterventionDrug
    National Institutes of Health Clinical Center (CC)
    January 2014 - January 2021
    10,002 Citations
    Citation Type

    Citation Type

    Cancer statistics, 2017
    • 10,652
    • PDF
    Cancer statistics, 2018
    • 5,401
    Trends in prostate cancer in the United States.
    • O. Brawley
    • Medicine
    • Journal of the National Cancer Institute. Monographs
    • 2012
    • 142
    • PDF
    Cancer statistics for Hispanics/Latinos, 2012
    • 516
    • PDF
    An updated report of the trends in cancer incidence and mortality in Japan.
    • 186
    • PDF
    Epidemiology, Incidence and Mortality of Breast Cancer in Asia.
    • 60
    • PDF
    Prostate Cancer Epidemiology
    • PDF
    Declining second primary ovarian cancer after first primary breast cancer.
    • 11
    Sex disparities in cancer mortality: the risks of being a man in the United States.
    • 39
    Contemporary incidence and mortality rates of kidney cancer in the United States.
    • G. Gandaglia, P. Ravi, +8 authors M. Sun
    • Medicine
    • Canadian Urological Association journal = Journal de l'Association des urologues du Canada
    • 2014
    • 67

    References

    SHOWING 1-10 OF 50 REFERENCES
    Trends in Breast Cancer by Race and Ethnicity
    • 461
    Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control
    • 988
    • PDF
    A New Method of Estimating United States and State‐level Cancer Incidence Counts for the Current Calendar Year
    • 107
    • PDF
    Impact of reporting delay and reporting error on cancer incidence rates and trends.
    • 238
    • PDF
    Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
    • 1,308
    • PDF
    Cancer Disparities by Race/Ethnicity and Socioeconomic Status
    • 1,403
    • PDF
    Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
    • 1,603
    • PDF
    Effect of screening and adjuvant therapy on mortality from breast cancer.
    • 823
    • PDF
    Quantifying the role of PSA screening in the US prostate cancer mortality decline
    • 335
    The global health burden of infection‐associated cancers in the year 2002
    • D. Parkin
    • Medicine
    • International journal of cancer
    • 2006
    • 2,576
    • PDF